Wendell David Associates Inc. Reduces Position in Roche Holding AG (OTCMKTS:RHHBY)

Wendell David Associates Inc. reduced its position in Roche Holding AG (OTCMKTS:RHHBY) by 4.7% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 12,100 shares of the company’s stock after selling 600 shares during the quarter. Wendell David Associates Inc.’s holdings in Roche were worth $422,000 as of its most recent SEC filing.

Several other institutional investors have also added to or reduced their stakes in the company. Kornitzer Capital Management Inc. KS increased its position in shares of Roche by 1.3% during the third quarter. Kornitzer Capital Management Inc. KS now owns 136,923 shares of the company’s stock worth $5,490,000 after acquiring an additional 1,798 shares during the period. Bard Financial Services Inc. increased its holdings in Roche by 37.7% during the 4th quarter. Bard Financial Services Inc. now owns 110,850 shares of the company’s stock worth $3,866,000 after purchasing an additional 30,350 shares during the period. Diversified Trust Co raised its position in Roche by 1.2% during the 4th quarter. Diversified Trust Co now owns 60,453 shares of the company’s stock valued at $2,130,000 after purchasing an additional 711 shares in the last quarter. Norman Fields Gottscho Capital Management LLC grew its position in shares of Roche by 5.5% during the 3rd quarter. Norman Fields Gottscho Capital Management LLC now owns 26,000 shares of the company’s stock worth $1,039,000 after buying an additional 1,350 shares in the last quarter. Finally, Confluence Investment Management LLC increased its stake in shares of Roche by 26.3% during the fourth quarter. Confluence Investment Management LLC now owns 13,981 shares of the company’s stock valued at $488,000 after buying an additional 2,910 shares during the period.

Roche Stock Up 1.0 %

Shares of RHHBY stock opened at $37.85 on Thursday. The company’s 50 day moving average is $35.74 and its 200 day moving average is $38.10. The company has a debt-to-equity ratio of 0.86, a current ratio of 1.26 and a quick ratio of 0.97. Roche Holding AG has a 52-week low of $29.20 and a 52-week high of $42.43.

Roche Profile

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation.